Immunosuppressive treatment for focal segmental glomerulosclerosis in adults

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Braun, Norbert ^a   Schmutzler, Frank ^b   Lange, Catalina ^a   Perna, Annalisa ^c   Remuzzi, Giuseppe ^d   Willis, Narelle S ^e  

^a HELIOS KLINIKEN SCHWERIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Istituto di Ricerche Farmacologiche   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINOGLYCOSIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; COTRIMOXAZOLE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PLACEBO; PREDNISOLONE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; BRONCHOSPASM; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPICONDYLITIS; FLUSHING; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERPLASIA; HYPERTRICHOSIS; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FUNCTION; LOW DRUG DOSE; MONOTHERAPY; NAUSEA; NEPHROTIC SYNDROME; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PARESTHESIA; PLASMAPHERESIS; PROTEINURIA; REMISSION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SYSTEMATIC REVIEW; TENDINITIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 55049120566     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003233.pub2     Document Type: Review

References (53)

1. Bhamik 2002 {published data only} Bhamik SK, Majumdar A, Barman SC. Comparison of pulse methylprednisolone vs cyclosporin based therapy in steroid resistant focal segmental glomerulosclerosis [abstract]. Indian Journal of Nephrology 2002;12(4):190. [CENTRAL: CN-00460392]
2. Cattran 1999 {published data only} Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, et al.A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney International 1999;56(6):2220-6. [MEDLINE: 10594798]
3. Imbasciati 1980 {published data only} Imbasciati E, Cagnoli L, Case N, Pasquali S, Di Filippo G, Limido D, et al.Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results. Minerva Nefrologica 1980;27(4):571-5. [MEDLINE: 7019771]
4. Ponticelli 1993 {published data only} Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, et al.A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney International 1993;43(6):1377-84. [MEDLINE: 8315953]
5. Bagga 2003 {published data only} Bagga A, Pankaj H, Moudgil A, Jordan SC. Mycophenolate Mofetil and Prednisolone therapy in children with steroid-dependent nephrotic syndrome. American Journal of Kidney Diseases 2003;42(6):1114-20. [MEDLINE: 14655181]
6. Bakir 1996 {published data only} Bakir AA, Share DS, Levy PS, Arruda JAL, Dunea G. Focal segmental glomerulosclerosis in adult African Americans. Clinical Nephrology 1996;46(5):306-11. [MEDLINE: 8953119]
7. Banfi 1991 {published data only} Banfi G, Moriggi M, Sabadini E, Fellin G, D' Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clinical Nephrology 1991;36(2):53-9. [MEDLINE: 1934660]
8. Beaufils 1978 {published data only} Beaufils H, Alphonse JC, Guedon J, Legrain M. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nephron 1978;21(2):75-85. [MEDLINE: 673092]
9. Bolton 1977 {published data only} Bolton WK, Atuk NO, Sturgill BC, Westervelt Jr FB. Therapy of the idiopathic nephrotic syndrome with alternate day steroids. American Journal of Medicine 1977;62(1):60-70. [MEDLINE: 835592]
10. Chan 1991 {published data only} Chan PC, Chan KW, Cheng IK, Chan MK. Focal sclerosing glomerulopathy. Risk factors of progression and optimal mode of treatment. International Urology & Nephrology 1991;23(6):619-29. [MEDLINE: 1769795]
11. Crenshaw 1999 {published data only} Crenshaw G, Bigler S, Salem M, Crook ED. Focal segmental glomerulosclerosis in African Americans: Effects of steroids and angiotensin converting enzyme inhibitors. American Journal of Medical Sciences 2000;319(5):320-5. [MEDLINE: 10830556]
12. Dantal 1998 {published data only} * Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, et al.Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. Journal of the American Society of Nephrology 1998;9(9):1709-15. [MEDLINE: 9727380]
13. Dudar 2004 {published and unpublished data} Dudar I, Kolesnik N, Velichko M, Vinnicova L. The result of pulse dose cyclophosphamide and ACE-inhibitor of focal segmental glomerulosclerosis/hyalinosis (FSGS/G) of patients with glomerulonephritis [abstract]. 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon (Portugal). 2004:39-40. [CENTRAL: CN-00509166]
14. El-Reshaid 1995 {published data only} El-Reshaid K, Amer E, Madda JP, Kapoor M. Long-term cyclosporin A treatment in adults with refractory nephrotic syndrome. Renal Failure 1995;17(6):695-703. [MEDLINE: 8771242]
15. Emre 2001 {published data only} Emre S, Oktem F, Denizem Y. Long term pulse methylprednisolone infusion therapy in patients with focal segmental glomerulosclerosis [abstract]. Pediatric Nephrology 2001;16(8):C115. [CENTRAL: CN-00445227]
16. Garin 1988 {published data only} Garin EH, Orak JK, Hiott KL, Sutherland SE. Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study. American Journal of Diseases of Children 1988;142(9):985-8. [MEDLINE: 3046332]
17. Goumenos 2006 {published data only} Goumenos DS, Tsagalis G, Meguid El Nahas A, Shortland JR, Davlouros P, Vlachojannis JG, et al.Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year followup study. Nephron 2006;104(2):c75-82. [MEDLINE: 16785738]
18. Grcevska 2006 {published data only} Grcevska L, Dzikova S, Petrusevska G, Polenakovic M. Prednisone/cyclophosphamide treatment in adult-onset autosomal dominant familial focal segmental glomerulosclerosis (FSGS 1). Clinical Nephrology 2006;65(6):461-2. [MEDLINE: 16792147]
19. Gulati 2000 {published data only} Gulati S, Kher V. Intravenous pulse cyclophosphamide - a new regime for steroid resistant focal segmental glomerulosclerosis. Indian Pediatrics 2000;37(2):141-8. [MEDLINE: 10745408]
20. Heering 2004 {published data only} Heering P, Braun N, Müllejans R, Ivens K, Zäuner I, Fünfstück R, et al.Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. American Journal of Kidney Diseases 2004;43(1):10-18. [MEDLINE: 14712422]
21. Ittel 1995 {published data only} Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Clinical Nephrology 1995;44(3):156-62. [MEDLINE: 8556831]
22. Lee 1995 {published data only} Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea. Clinical Nephrology 1995;43(6):375-81. [MEDLINE: 7554521]
23. Lieberman 1996 {published data only} Lieberman KV, Tejani A. A randomized double-blind placebo-controlled trial of Cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. Journal of the American Society of Nephrology 1996;7(1):56-63. [MEDLINE: 8808110]
24. Medizábal 2005 {published data only} Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatric Nephrology 2005;20(7):914-9. [MEDLINE: 15891923]
25. Meyrier 1986 {published data only} Meyrier A, Simon P, Perret G, Condamin-Meyrier MC. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. British Medical Journal (Clinical Research Ed.) 1986;292(6523):789-92. [MEDLINE: 3082443]
26. Meyrier 1989 {published data only} Meyrier A, Bacri JL, Bagros P, Lebranchu Y, Bataille P, Baumelou A, et al.Ciclosporin in the treatment of nephrosis. Minimal change disease and focal-segmental glomerulosclerosis. American Journal of Nephrology 1989;9 Suppl 1:65-71. [MEDLINE: 2646928]
27. Meyrier 1994 {published data only} Meyrier A, Noel LH, Auriche P, Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney International 1994;45(5):1446-56. [MEDLINE: 8072258]
28. Mowry 1993 {published data only} * Mowry J, Marik J, Cohen A, Hogg R, Sahney S, Ettenger R. Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis. Transplantation Proceedings 1993;25(1 Pt 2):1345-6. [MEDLINE: 8442138]
29. Nagai 1994 {published data only} Nagai R, Cattran DC, Pei Y. Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly. Clinical Nephrology 1994;42(1):18-21. [MEDLINE: 7923961]
30. Pei 1987 {published data only} Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. American Journal of Medicine 1987;82(5):938-44. [MEDLINE: 3578362]
31. Ponticelli 1999 {published data only} Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, et al.Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?. American Journal of Kidney Diseases 1999;34(4):618-25. [MEDLINE: 10516340]
32. Raafat 2004 {published data only} Raafat RH, Kalia A, Travis LB, Diven SC. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. American Journal of Kidney Diseases 2004;44(1):50-6. [MEDLINE: 15211437]
33. Rydel 1995 {published data only} Rydel JJ, Korbet SM, Borok RZ, Schwartz MM. Focal segmental glomerular sclerosis in adults: presentation, course and response to treatment. American Journal of Kidney Diseases 1995;25(4):534-42. [MEDLINE: 7702047]
34. Tarshish 1996 {published data only} Tarshish P, Tobin, JN, Bernstein J, Edelmann Jr CM. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. Pediatric Nephrology 1996;10(5):590-3. [MEDLINE: 8897562]
35. Walker 1990 {published data only} Walker RG, Kincaid-Smith P. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin. Nephron 1990;54(2):117-21. [MEDLINE: 2179754]
36. Xia 2003 {published data only} Xia ZK, Liu GL, Gao YF, Fu J, Fu YF, Zhang LF, et al.Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types. Zhonghua Erke Zazhi 2003;41(11):813-6. [MEDLINE: 14728885]
37. Chan 2003 {published data only} Chan D. Mycophenolate mofetil in membranous nephropathy and focal segmental. ClinicalTrials.Gov, National Institutes of Health [http://www.clinicaltrials.gov] 2003. [: NCT00404833]
38. Friedman 2004 {published data only} Friedman A, Gassmann J. Focal segmental glomerulosclerosis clinical trial (FSGS-CT). ClinicalTrials.Gov, National Institutes of Health [http://www.clinicaltrials. gov] 2004. [: NCT00135811]
39. Liu 2006 {published data only} Liu Z. Tacrolimus treatment of patients with idiopathic focal segmental glomerulosclerosis. ClinicalTrials.Gov, National Institutes of Health [http://www.clinicaltrials. gov] 2006. [CENTRAL: CN-00583312; : NCT00302536]
40. NIDDK 2003 {published data only} National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Pulse dexamethasone over 48 weeks for podocyte disease. ClinicalTrials.Gov, National Institutes of Health [http://www.clinicaltrials.gov] 2003. [: NCT00065611]
41. Trachtman 2005 {published data only} Trachtman H, Gipson D, Greene T. Pilot studies of novel therapies to treat resistant focal segmental glomerulosclerosis (FSGS). ClinicalTrials.Gov, National Institutes of Health [http://www.clinicaltrials.gov] 2005. [: NCT00193648]
42. Bohle 1986 Bohle, GHV. Die Niere. Stuttgart: Schattauer, 1986.
43. Burgess 1999 Burgess E. Management of focal segmental glomerulosclerosis: evidence based recommendations. Kidney International - Supplement 1999;70:S26-32. [MEDLINE: 10369192]
44. Glassock 1993 Glassock RJ. Therapy of idiopathic nephrotic syndrome in adults. A conservative or aggressive therapeutic approach?. American Journal of Nephrology 1993;13(5):422-8. [MEDLINE: 8116694]
45. Kincaid-Smith 1978 Kincaid-Smith P, Yeung CK. Focal and segmental proliferative glomerulonephritis, focal and segmental hyalinosis and sclerosis, and focal sclerosis in the adult. Glomerulonephritis. New York: John Wiley & Sons, 1978:231-45.
46. Korbet 1994 Korbet S, Schwartz M, Lewis E. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. American Journal of Kidney Diseases 1994;23(6):773-83. [MEDLINE: 8203357]
47. Meyrier 1999 Meyrier A. Treatment of primary focal segmental glomerulosclerosis. Nephrology, Dialysis, Transplantation 1999;14 Suppl 3:74-8. [MEDLINE: 10382986]
48. Schulman 1988 Schulman SL, Kaiser BA, Polinsky MS, Srinivasan R, Baluarte HJ. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: Superiority of response to corticosteroid therapy over histopathologic patterns. Journal of Pediatrics 1988;133(3):996- 1001. [MEDLINE: 3193322]
49. Thomas 2006 Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, et al.Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney International 2006;69(5):920-6. [MEDLINE: 16518352]
50. Tune 1995 Tune BM, Kirpekar R, Sibley RK, Reznuk VM, Grisworld WR, Mendoza SA. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clinical Nephrology 1995;43(2):84-8. [MEDLINE: 7736683]
51. Valeri 1996 Valeri A, Barisoni L, Appel GB, Seigle R, D' Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney International 1996;50(5):1734-46. [MEDLINE: 8914044]
52. Velosa 1983 Velosa JA, Holley KE, Torres VE, Offord KP. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clinic Proceedings 1983;58(9):568-77. [MEDLINE: 6887974]
53. Von Graffenried 1991 Von Graffenried B, Feutren G, Schiess W, Rohrmann C, Brodehl J Meyrier A, et al.Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Clinical Nephrology 1991;35 Suppl 1:S48-60. [MEDLINE: 1860268]